Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 1997, for Nature's Sunshine Products, Inc., a Utah-based company engaged in the direct sales of natural health and nutritional products. The company operates through a network of independent Managers and Distributors, with significant international expansion.
Key Financial Metrics
Revenue and Profit (Nine Months Ended Sept 30, 1997):
- Sales Revenue: $210.8 million (up 13.2% from prior year).
- Net Income: $14.7 million (up 20.6% from prior year).
- Earnings Per Share: $0.77 (up from $0.62).
- Operating Income: $22.5 million (up 17.0% from prior year).
Cash Flow and Liquidity:
- Cash and Cash Equivalents: $27.0 million (decreased $0.9 million from year-end 1996).
- Operating Cash Flow: $19.4 million provided by operations.
- Short-term Debt: $2.7 million.
- Working Capital: Current assets of $67.5 million against current liabilities of $30.9 million.
Margins (Nine Months):
- Gross Margin (Sales less COGS): Approximately 81.9%.
- Operating Margin: 10.7%.
- Net Profit Margin: 6.96%.
Material Changes vs. Prior Period
Revenue Growth: Sales increased 13.6% for the quarter and 13.2% for the nine-month period. This growth was driven by a 23% increase in the number of Managers (to 14,417) and a 19% increase in Distributors (to 624,000). International sales grew 17% to $77.0 million, while domestic sales grew 11% to $133.8 million.
Expense Trends:
- Volume Incentives: Increased to $98.1 million (46.6% of sales), reflecting higher sales volume.
- SG&A Expenses: Increased in absolute dollars but decreased as a percentage of sales (24.6% vs 25.9% prior year) due to management efficiency.
- Cost of Goods Sold: Slight increase as a percentage of sales (18.1% vs 17.8%) attributed to international operations.
Capital Allocation: The company significantly increased treasury stock purchases, spending $19.2 million to acquire 1.1 million shares during the first nine months of 1997, which was the primary driver for the decrease in cash balances.
Outlook, Risks, and Management Commentary
Management Outlook: Management expects Cost of Goods Sold and Volume Incentives to remain relatively constant as a percentage of sales for the remainder of 1997. SG&A is expected to decrease slightly as a percentage of sales.
Capital Projects:
- Manufacturing Expansion: Domestic facility expansion is projected to cost $6.0 million to $7.0 million.
- International Expansion: A new subsidiary in South Korea may require $0.5 million to $1.0 million in funding.
- Financing: The company may consider long-term financing for these projects if funded from working capital.
Risks and Contingencies:
- Foreign Exchange: International operations expose the company to currency fluctuations, resulting in a net foreign exchange loss of $0.25 million for the nine-month period.
- Legal/Regulatory: The company is subject to incidental lawsuits and regulatory changes, though management does not expect a material effect on financial position.
Investor Verification Checklist
- Verify the sustainability of the 13% sales growth rate given the heavy reliance on independent distributor volume.
- Monitor the impact of the $19.2 million stock buyback on future liquidity and ability to fund the $6.5 million+ in planned capital projects.
- Review the performance of the new South Korea subsidiary and the Asia Pacific segment, which reported a loss of $0.6 million in operating income for the nine-month period.
- Confirm the stability of the "Volume Incentives" ratio (approx. 46.5% of sales) as a key cost driver.
- Check for any updates on the pending implementation of SFAS No. 128 regarding earnings per share calculations.